RheumaGen
Denver, CO
RheumaGen is a gene-editing technology developing therapeutics to cure rheumatoid arthritis. It offers an HLA gene-editing platform that uses stem-cell-enriched blood to alter DNA to suppress the immune system and stop rheumatoid arthritis's abnormal immune response.
rheumagen.comCompany Details
Founded
- 2019
Employees
- Between 5 - 10 employees
Raised
- $4,906,587
Headquarters Location
- Denver, CO
Public
- No
Acquired
- No
CEO
- N/A
Founders
- Brian Hart
Company Collections
These are collections RheumaGen is a part of. Click on the collection name to view similar companies.